We lead the fight against recurrent prostate cancer

The aim of SpectraCure’s proprietary and patented treatment system is to eliminate internal cancer tumors and extend the survival of cancer patients. Our technology is based on PDT treatment with IDOSE®. 

Our therapeutic system is suitable for internal solid tumours of various kinds, such as prostate and pancreas. In the future, we aim to make it possible to treat other cancers such as cancer of the breast and in the head and neck region. With our therapeutic system, the aim is to preserve a good quality of life for the patients.

The method has great potential to limit side effects, and the patient will be able to leave the hospital within a few hours after treatment. If you suffer from recurrent prostate cancer, there is often no other alternative than hormone treatment for the rest of your life. SpectraCure can now change this!

READ MORE

PRESS RELEASES

FINANCIAL REPORTS (SWEDISH)

SPECTRACURE DEVICE 2

Presentations

PLAY

Subscribe

When submitting a subscription to press releases, quarterly reports and annual reports, your email address will be forwarded to SpectraCures, which handles the mailing service. For more information, see SpectraCures Integritetspolicy.
All Interim reports and Annual reports are in Swedish.